Also, regarding microarrays, it is noteworthy that the so-called DTC (Direct-to-Customers) Genome Testing is also grabbing a lead-role with the Illumina arrays (e.g. by 23andMe, that has just catapulted its marketing model with the help of a more potent array by Illumina).

FORBES: Biotech's Biggest Winner